0GWJ.L Stock Analysis
0G
Uncovered
Clinica Baviera SA is uncovered by Eyestock quantitative analysis.
Market cap $B
0.62
Dividend yield
4.92 %
Shares outstanding
16.302 B
Clínica Baviera SA is engaged in the provision of diagnosis and treatment for eye disorders. The company is headquartered in Madrid, Madrid. The company went IPO on 2000-01-01. The firm focuses on providing services within the field of ophthalmic medicine. The firm is specialized in the diagnosis and treatment of eye disorders, including myopia, hyperopia, astigmatism, cataracts, glaucoma, vitreous-retina and strabismus, among others. The firm operates a network of clinics located in various European countries, such as Spain, Germany, Austria and Italy. In addition, the Company is a parent of the Baviera Group, a group that comprises a number of controlled entities, including Clinica Baviera Italia Srl, Clinica Baviera Mallorca SL, Care Vision Germany GmbH and Castellana de Intermediacion Sanitaria SL, among others. The main shareholder of the Company is Aier Eye International (Europe) Slu.